Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 85 results for "biocon"

Biocon jumps after receiving EIR from USFDA

after the company said its facility has been cleared by the US drug regulator after an inspection. The announcement was made before trading hours today, 20 November 2017. Meanwhile, the S BSE Sensex was up 5.10 points, or 0.02% to 33,347.90. On the BSE, 2.39 ... Business Standard, 1 day ago
Biocon gains 5.6% on EIR from USFDA Money Control, 1 day ago

50 images for biocon

Sify, 1 day ago
Money Today, 1 day ago
Business Standard, 1 day ago
Business Standard, 1 day ago
Money Control, 2 days ago
Money Control, 2 days ago
Money Control, 1 week ago
Business Standard, 1 week ago
Money Control, 3 weeks ago
Business Standard, 3 weeks ago
Money Control

Market Update: GAIL, Yes Bank top Nifty gainers; ICICI Bank falls 2%, IndusInd, HDFC most active

The midcap Index outperformed and was up 0.49 percent led by Biocon which jumped over 5 percent on the back of EIR received from USFDA followed by Godrej Industries, Jain Irrigation, Mcleod Russel, SAIL, OBC and Tata Global Beverage.
 Money Control1 day ago Stocks in the news: LT, AstraZeneca, Biocon, Lupin, Yes Bank, Divis, Eris, RCom, Voltas  Money Control2 days ago Market Update: Biocon zooms over 7% as midcaps outperform; BPCL, HPCL top gainers, ONGC down 3%  Money Control6 days ago Market Update: Nifty clings above 10K as midcaps shine; Bharti Infratel, Hindalco top gainers  Money Control1 month ago
Business Standard

Biocon gains over 7% after receiving EIR from USFDA

The stock surged 7% to Rs 420 on the BSE in early morning deal, trading close to its 52-week high of Rs 424 touched on July 19, 2017 in intra-day trade Last Updated at November 20, 2017 09:55 IST Biocon Biocon surged 7% to Rs 420 on the BSE in early morning ...
 Business Standard1 day ago Biocon jumps after Malaysia facility receives compliance certificate  Business Standard2 months ago Biocon gains as insulin facility in Malaysia gets GMP nod  Business Standard2 months ago Biocon rallies 5% on Europe GMP approval for Malaysian insulin facility  Money Control2 months ago

Biocon jumps on green signal for US export

Shares of Biocon Ltd surge as much as 6.4 pct, their biggest intraday pct gain since Nov. 17. Co's aseptic drug product facility gets Establishment Inspection Report (EIR) with voluntary action indicated (VAI) status from U.S. Food and Drug Administration.
 Sify1 day ago BUZZ-India's Biocon gains; co says FDA letter not to hit US drug launch  Sify1 month ago Indian shares edge higher; metal stocks extend rally  Sify2 months ago BUZZ-India's Biocon hits 1-month high; receives EU compliance certificate  Sify2 months ago
Money Today

Biocon stock closes 7.27% higher on inspection closure report from USFDA

The Biocon stock closed 7.57 percent higher in Monday's trade after the biotechnology firm said it has received the Establishment Inspection Report with 'voluntary action indicated' status from the USFDA on closure of inspection of its aseptic drug product ...
 Money Today1 day ago Biocon facility gets inspection closure report from USFDA  Business Standard1 day ago Biocon shares up 7% as facility gets inspection closure report  Business Standard1 day ago Biocon stock closes higher as Malaysia arm gets GMP compliance certificate  Money Today2 months ago

Nandan Nilekani, wife Rohini to donate part of their wealth to Bill Gates' charity organisation

After the donation, the Nilekanis will join the league of other Indian billionaires like Wipro Chairman Azim Premji, Biocon Chairman & Managing Director Kiran Mazumdar Shaw, and Sobha Ltd Chairman P N C Menon, who already are part of the global movement for ...
 DNA1 day ago Nilekanis donate half their wealth to philanthropy  Sify20 hours ago Nilekanis pledge half their wealth for philanthropy  Deccan Herald1 day ago
Money Control

Syngene expands research tie-up with Bristol-Myers

Biocon's contract research arm Syngene International on Tuesday announced it was expanding partnership with the US pharma major Bristol-Myers Squibb (BMS) for more research and development (R&D) of drugs."As part of the expansion, a new facility will be set ...
 Prokerala1 week ago Biocon arm widens partnership terms with Bristol-Myers Squibb  Money Control1 week ago
Business Standard

Biocon gains 2% as Mylan resubmits marketing authorization applications to EMA

Biocon’s partner Mylan has resubmitted the marketing authorization applications (MAAs) for its proposed biosimilar trastuzumab and pegfilgrastim with the EMA as per the administrative protocol.
 Money Control2 weeks ago Biocon intimates of resubmission of biosimilar trastuzumab and pegfilgrastim with EMA  Business Standard2 weeks ago
Business Standard

Price controls will devalue healthcare system in India: Kiran Mazumdar-Shaw

Kiran Mazumdar Shaw, chairman and managing director of Biocon has called on the Centre to be careful in controlling prices of drugs and equipment saying that this could potentially impact the quality of healthcare in India. "I think there is an affordability ...
 Business Standard1 week ago

US regulator audits Biocon drug facility in Bengaluru

Indian biotech major Biocon Ltd on Monday said the US Food and Drug Administration (FDA) had audited its aseptic drug product facility here and issued an establishment inspection report on its current good manufacturing practice."The FDA had audited our drug ...
 Prokerala1 day ago Biocon rises 3% on zero observation from USFDA  Money Control2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less